English
Español

(805) 483 1185

Participate in a study!

Linkedin-in Instagram Facebook-f
01 Fomat_Logo_Website-min
proud-partner-HCI-V6
  • Home
  • About Us
  • For Sponsors & CROs
    • Services For Sponsors & CROs
    • Our Capabilities
      • eClinical Trials
      • NASH Capabilities
      • COVID Solutions
      • Vaccine Capabilities
  • For Patients
  • News & Updates
  • Contact FOMAT
  • │Fomat LatAm
  • US Careers

Home » alltrials

Posts tagged: alltrials

carousel

With Opdivo approval, Bristol-Myers arms for PD-1 battle against Merck’s Keytruda

December 24, 2014
by fomat_medical Blogs & Updates

With Opdivo approval, Bristol-Myers arms for PD-1 battle against Merck's Keytruda  The Bristol-Myers Squibb-vs.-Merck match in melanoma is on. Bristol-Myers ($BMY) scored FDA approval for its cancer immunotherapy Opdivo (nivolumab) three months ahead ...

Read More
0
shutterstock_kidneys2

Researchers Find Alternate Drug Therapy Lowers Antibodies

December 24, 2014
by fomat_medical Blogs & Updates

Researchers Find Alternate Drug Therapy Lowers Antibodies  Findings of a three-year clinical trial led by University of Cincinnati (UC) transplant researchers suggest that a novel pre-operative drug therapy reduces antibodies in kidney patients with ...

Read More
1
shutterstock_cancer cells_11

Researchers Map Paths to Cancer Drug Resistance

December 24, 2014
by fomat_medical Blogs & Updates

Researchers Map Paths to Cancer Drug Resistance  A team of researchers led by Duke Cancer Institute has identified key events that prompt certain cancer cells to develop resistance to otherwise lethal therapies By mapping the specific steps that cell ...

Read More
0
Cancer cells, 3d illustration

Cancer Drug Destroys Tumors in Pre-Clinical Trials

October 13, 2014
by fomat_medical Blogs & Updates

Scientists at QIMR Berghofer Medical Research Institute have used an experimental drug produced from the seeds of a rainforest plant to cure solid cancer tumors in preclinical trials.  The study led by Dr. Glen Boyle at QIMR Berghofer’s Cancer Drug ...

Read More
0

Recent Posts

  • FOMAT Continues to Encourage Diversity in Clinical Trials throughout California
  • FOMAT Unveils Pioneering Phase 1 Capabilities: Championing Diversity in Clinical Trials and Enhancing Patient Care
  • Simon Corman Joins FOMAT to Help Innovate Healthcare Through Diversity
  • Innovating Our Services Alongside Our Ambulance of Research!
  • We are hiring a Project Manager! 

Categories

  • Aids
  • Allergies | Allergens
  • Alzheimer
  • Blogs & Updates
  • Breast Cancer
  • Cancer
  • Clinical Trials
  • Colds and Flu
  • Company Updates
  • Coronavirus
  • CRO Contract Research Organization
  • Crohn's Disease
  • Diabetes
  • Diseases
  • Disorders
  • Drug Discovery and Research
  • Ebola
  • eClinical Trials
  • Fertility Drugs
  • General
  • Lung Cancer
  • Marijuana
  • Medical Devices
  • Memory Loss
  • News
  • Research Studies
  • Social Media
  • Vaccines
  • Whitepapers

Upcoming Events

DIA 2023 Global Annual Meeting

June 25-29, 2023

Boston, MA

Contact Us

FOMAT Medical Research INC,
300 South A Street Suite 201 Oxnard, CA 93030
(805) 483 1185
Trial Information: [email protected]
General Information: [email protected]
  • Review us on Google
  • Review us on Yelp

Site Map | Privacy Policy

Shopping Basket